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Abstract Acute generalized exanthematous pustulosis
(AGEP) and generalized pustular psoriasis (GPP) are rare
pustular skin disorders with systemic involvement. IL-17A/
F is a proinflammatory cytokine involved in various neu-
trophilic inflammatory disorders. Here we show that IL-
17A/F is highly expressed by innate immune cells such as
neutrophils and mast cells in both AGEP and GPP.
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Abbreviations
AGEP Acute generalized exanthematous pustulosis
GPP Generalized pustular psoriasis
IL-36Ra IL-36 receptor antagonist
Th17 T helper 17
IL-17 Interleukin 17A/F
Introduction
Acute generalized exanthematous pustulosis (AGEP) is a
rare drug-induced skin reaction. It is characterized by an
acute erythematous rash with numerous sterile pustules,
accompanied by fever and neutrophilia [18]. Drug specific
T cells are implicated in pathogenesis of AGEP, some of
which have been shown to exhibit a phenotype consistent
with Th17 cells [1, 15, 16].
Generalized pustular psoriasis (GPP) is characterized by
recurrent eruptions of sterile pustules on erythematous
skin, high-grade fever and neutrophilia. In GPP and in a
subset of AGEP, mutations of the IL-36 receptor antagonist
(IL-36Ra) have been shown to lead to unregulated secre-
tion of inflammatory cytokines [10].
IL-17A/F and Th17 cells have been identified as key
players in the pathogenesis of auto-inflammatory disease. IL-
17A/F is a potent inducer of tissue inflammation and neutro-
phil recruitment [12]. Although the key role of IL-17A/F/
Th17 cells in the pathogenesis of plaque psoriasis is well
described [5], its expression in AGEP and GPP has not been
studied in detail. Therefore, we sought to investigate the
expression and distribution of IL-17A/F and its cellular source
in AGEP and GPP in comparison to normal human skin.
Materials and methods
Samples from patients
The study was approved by the local Medical Ethics
Committee. After informed consent, tissue samples were
obtained from patients with AGEP (n = 8) and GPP
(n = 8). Diagnosis was based on the EuroSCAR validation
score [2] for AGEP and on clinical and histological
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features for GPP. Normal skin was obtained from healthy
individuals who underwent surgery for esthetic reasons
(n = 7, median age 50 years).
The culprit drugs identified in our patients included amox-
icillin–clavulanic acid (2 patients), terbinafine (2 patients),
amoxicillin, clarithromycin, clindamycin and ibuprofen.
GPP samples were from 8 patients (5 female and 3 male)
with the median age of 58 years (range 22–89 years).
Immunohistochemistry and immunofluorescence
Tissue sections from formalin-fixed, paraffin-embedded
blocks were used for immunohistochemical and immuno-
fluorescence staining as previously described [17, 22].
Goat anti-human IL-17A/F (AF-317-NA, R&D), rabbit
anti-human CD3 (A0452, DAKO), mouse anti-human CD68
(EBM11, DAKO), mouse anti-human CD66b (555723,
Becton–Dickinson), and rabbit anti-human mast cell tryptase
(sc-32889, Santa Cruz) were used. For detecting IL-17A/F a
goat HRP polymer kit (GHP516H, Biocare Medical) was
used. For double immunohistochemistry both the goat HRP
polymer kit and MACH4 Universal mouse/rabbit AP-Poly-
mer Kit (M4U536H, Biocare Medical) were used.
IL-17A/F was detected by immunofluorescence using
either donkey anti-goat/Alexa Fluor 488 (A–11055) or
rabbit anti-goat/Alexa Fluor 488 (A-11078). CD3 and mast
cell tryptase were detected with donkey anti-rabbit/Alexa
Fluor 594 (A-21207), CD68 was detected with a rabbit
anti-mouse/Alexa Fluor 594 (A-11062), all from Invitro-
gen. Eosinophil cationic protein (ECP) was detected with
monoclonal mouse anti-human ECP antibody (Pharmacia
Diagnostics AB, Sweden) followed by goat anti-mouse
IgG2a/Alexa Fluor594 (A21135, Invitrogen).
Quantitative analysis was performed using the digital
image analysis system NIS-Elements Software BR 2.30 by
two independent observers and 3 HPF/biopsy, as previ-
ously described [22]. Papillary dermis was defined as the
part of the dermis that is intertwined with the rete ridges of
the epidermis and is composed of fine and loosely arranged
collagen fibers. The reticular dermis was defined as the part
of the dermis under the papillary dermis, composed of
dense irregular connective tissue.
In-situ hybridization
35S-labeled sense and antisense IL-17A/F mRNA probe,
333 bp in length and corresponding to position 143–475 bp
of the human IL-17A/F sequence (NM_002190.2), were
generated by in vitro transcription (10 999 644 001,
Roche). In situ hybridization was performed as previously
described [11, 23].
Results
IL-17A/F positive cells in AGEP, GPP and normal skin
In normal skin, few IL-17A/F? cells were observed in the
upper dermis only (Fig. 1a). In AGEP, IL-17A/F? cells
were found in subcorneal pustules and, to a lesser extent, in
the epidermis near pustules and the upper dermis (Fig. 1b).
Similar findings were seen in GPP (Fig. 1c). Quantitative
analysis of IL-17A/F? cells confirmed statistically signifi-
cant differences in IL-17A/F expression between normal
skin and AGEP and GPP, respectively (Fig. 1d).
In situ IL-17A/F mRNA expression
To confirm IL-17A/F gene expression in the skin, in situ
hybridization was performed (Fig. 1h–j). IL-17A/F tran-
script expression was detected in normal skin, AGEP, and
GPP. IL-17A/F mRNA co-localized with IL-17A/F protein
expression, as detected by immunohistochemical staining
in consecutive slides (Fig. 1e–g), thus confirming IL-17A/
F production in situ.
Double immunostaining
To determine the phenotype of cells expressing IL-17A/F,
double immunohistochemical staining was performed with
markers for neutrophils (CD66b) or T-lymphocytes (CD3)
(Fig. 2a–f). In both AGEP and GPP, almost all cells in
subcorneal pustules were CD66b?/IL-17A/F? neutrophils
(Fig. 2a, c). In the epidermis and upper dermis, some IL-
17A/F?/CD66b- cells were seen (Fig. 2a–c). The few
CD3? cells found in pustules did not co-express IL-17A/F
(Fig. 2d, f). In the dermis, only a few IL-17A/F?/CD3? T
cells were observed (Fig. 2e). Therefore, neutrophils
appear to be the main source of IL-17A/F in pustules.
Furthermore, double immunofluorescence analysis was
performed using markers for T-lymphocytes (CD3), mac-
rophages and dendritic cells (CD68), mast cells (tryptase)
(Fig. 3a–c) and for eosinophils (eosinophil cationic pro-
tein; ECP [19]; Suppl. Fig. 1). In both AGEP and GPP, IL-
17A/F co-localized frequently with tryptase and CD68,
respectively. CD3?/IL-17A/F? cells were only scarcely
detected, whereas eosinophils where not found to express
any IL-17A/F in AGEP.
Discussion
Here we demonstrate on both the mRNA and the protein
level that IL-17A/F-expressing cells are significantly
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Fig. 1 IL-17A/F expression in normal skin, AGEP, and GPP.
Representative immunohistochemical staining of IL-17 in the skin
of a normal control, b acute generalized exanthematous pustulosis
(AGEP), and c generalized pustular psoriasis (GPP). d The number of
IL-17 positive cells in epidermis without pustules, upper dermis, and
deep dermis of AGEP, GPP, and normal skin. For GPP, data points
with red center indicate patients with ‘‘GPP ? PV’’, data points with
white center indicate patients with ‘‘GPP without PV’’. Mann–
Whitney U test. *p \ 0.05, **p \ 0.01, ***p \ 0.001, n.s. not
significant. e–h Immunohistochemical analysis of IL-17A/F expres-
sion in normal skin, AGEP and GPP. i–p Analysis of IL-17 mRNA
tissue expression performed by in situ hybridization on serial sections
shows co-localization of IL-17 mRNA (i–l) with IL-17 protein (e–h).
Original magnification 9100 (a–c), 9200 (e–j), insets 9800 (e–g, i–
k). IHC immunohistochemistry, ISH in situ hybridization
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increased in subcorneal pustules, epidermis and dermis
of AGEP and GPP as compared to normal skin. Fur-
thermore, we show that innate immune cells such as
neutrophils and mast cells are important cellular sources
of IL-17A/F, while T cells account only for a minority
of the total IL-17A/F-expressing cells. Our data are
consistent with previous reports showing that mast cells
and neutrophils rather than T cells are the predominant
source of IL-17A/F in skin lesions of plaque psoriasis
[7–9, 21].
In our study, IL-17 expression by neutrophils was
assessed by in situ co-localization of both IL-17A/F mRNA
and protein with CD66b. In humans, CD66b is expressed
constitutively by neutrophils and eosinophils and CD66b
expression levels increase upon granulocyte activation
[24]. Since neutrophils have been shown to express IL-
17A/F after stimulation with IL-6 and IL-23, co-expression
of IL-17 found in our study may indicate simultaneous
upregulation of CD66b and IL-17 in neutrophils as a
consequence of cytokine stimulation by IL-6 and IL-23,
both of which are cytokines intimately linked to the path-
ogenesis of psoriasis [3, 8]. To further confirm IL-17
expression by neutrophils, we excluded relevant expression
of IL-17 by CD66b? eosinophils in AGEP (Suppl. Fig. 1).
In GPP and normal skin, eosinophils are not part of the
immune infiltrate.
In addition to neutrophils and mast cells, macrophages
have also been shown to be an important cellular source
of IL-17 in murine and human inflammation, most
prominently in lung inflammation [4, 20]. Interestingly,
we did observe co-localization of IL-17 with CD68?
cells in our immunofluorescence study, indicating that
also in human skin inflammation, macrophages and
dendritic cells can produce IL-17. However, our data
does not rule out the possibility that an uptake of frag-
ments from IL-17-producing cells could also explain the
detection of IL-17A/F in macrophages. Further studies
are needed to determine the contribution of macrophages
to the production of IL-17 in cutaneous inflammation.
AGEP and GPP share clinical, genetic, histological, and
immunological features [14]. In accordance with previous
data, we show that high in situ expression of IL-17A/F is
yet another similarity between the two diseases [6, 13]. IL-
17A/F induces IL-36 expression in keratinocytes and IL-36
can induce further proinflammatory signals. Interestingly,
loss of function in antagonism of IL-36 based on mutations
in the IL-36 receptor antagonist IL-36Ra can cause GPP
and IL-36Ra mutations can also be found in a subset of
AGEP patients [2, 10, 14]. Therefore, in both GPP and
AGEP, activation of keratinocytes by IL-17A/F may
enhance local IL-36 expression, which—in the absence of
functional antagonism—then drives neutrophil tissue
inflammation.
Taken together, our findings position IL-17A/F
expression as a common pathogenetic step in both AGEP
and GPP, help to explain the similarity of their clinical
presentation, and provide a rationale for a therapeutic
approach with modern antibodies against IL-17A/F.
Fig. 2 Double immunohistochemical staining for IL-17 with CD3 (T
cells), CD66b (neutrophils) (a–c). Immunohistochemical double
staining of IL-17 (brown) and CD66b (red) in AGEP (a, b) and
GPP (c). d–f Immunohistochemical double staining of IL-17 (brown)
and CD3 (red) in AGEP (d, e) and GPP (f). Original magnification
9200 (a, c, d, f) or 9400 (b, e)
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Fig. 3 Double immunofluorescence staining for IL-17 with CD3 (T
cells), tryptase (mast cells), or CD68 (macrophages/dendritic cells).
Double immunofluorescence staining of IL-17 in green with CD3 (a),
mast cell tryptase (b), or CD68 (c) all in red in normal skin, AGEP,
and GPP. Arrows indicate examples of IL-17-single positive cells,
arrow heads indicate examples of IL-17-positive cells co-expressing
the indicated markers. Nuclei were counterstained by DAPI (blue).
(Original magnification 9800)
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